PeptideDB

c-ABL-IN-1

CAS: 2304918-82-7 F: C17H16Cl2FN3OS W: 400.30

c-ABL-IN-1 is a novel selective c-Abl inhibitor that prevents neurodegeneration in parkinson’s disease.
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity c-ABL-IN-1 is a novel selective c-Abl inhibitor that prevents neurodegeneration in parkinson’s disease.
Name c-ABL-IN-1
CAS 2304918-82-7
Formula C17H16Cl2FN3OS
Molar Mass 400.30
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Kwon SH, et al. A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease. J Med Chem. 2021 Oct 28;64(20):15091-15110.